Patient Wars in The Pharmaceutical Industry: Balancing Access to Medicine and Innovation

The global pharmaceutical sector is strategically positioned at the nexus of innovation and public health, both competing as a necessary interest in groundbreaking medical treatments and an urgent concern over the availability of healthcare. Patent Wars in the Pharmaceutical Industry: Balancing Access to Medicine and Innovation, a work that examines the intricate balance between intellectual property rights and the impact of life-saving medicines examining the controversial discourses. Pharma patents fuel innovation, as unique rights to market (allowing companies to recover the expense of R&D productions) But their existence as monopolies also implies high drug prices and the disadvantaged position of many patients in low- and middle-income countries, thus posing challenges to planetary health equity. This study provides a critical historical overview of the response to Intellectual Property due to changes in the communications technologies that lead to unauthorized use and sharing, from both perspectives of austerity and re-state intervention. The examples are drawn from different geographies and pharmaceutical markets, analyzing how the patent laws can either spur medical advances or subvert efforts to ensure affordable access. In sum, this work argues for a new language of pharmaceutical IP, one that can secure innovation while redressing the right to health on an international scale.